Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Major depressive and bipolar disorders predispose to atherosclerosis, and there is accruing data from animal model, epidemiological, and genomic studies that commonly used antihypertensive drugs may have a role in the pathogenesis or course of mood disorders. In this study, we propose to determine whether antihypertensive drugs have an impact on mood disorders through the analysis of patients on monotherapy with different classes of antihypertensive drugs from a large hospital database of 525 046 patients with follow-up for 5 years. There were 144 066 eligible patients fulfilling the inclusion criteria: age 40 to 80 years old at time of antihypertensive prescription and medication exposure >90 days. The burden of comorbidity assessed by Charlson and Elixhauser scores showed an independent linear association with mood disorder diagnosis. The median time to hospital admission with mood disorder was 847 days for the 299 admissions (641 685 person-years of follow-up). Patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers had the lowest risk for mood disorder admissions, and compared with this group, those on β-blockers (hazard ratio=2.11; [95% confidence interval, 1.12–3.98]; P =0.02) and calcium antagonists (2.28 [95% confidence interval, 1.13–4.58]; P =0.02) showed higher risk, whereas those on no antihypertensives (1.63 [95% confidence interval, 0.94–2.82]; P =0.08) and thiazide diuretics (1.56 [95% confidence interval, 0.65–3.73]; P =0.32) showed no significant difference. Overall, our exploratory findings suggest possible differential effects of antihypertensive medications on mood that merits further study: calcium antagonists and β-blockers may be associated with increased risk, whereas angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be associated with a decreased risk of mood disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
(2013) · The Lancet · doi:10.1016/s0140-6736(12)62129-1 · Cited by 3,010
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Wellcome Trust Case Control Consortium, Ferreira, M. A. R., O'Donovan, M. C., Meng, Y. A., Jones, I. R., Ruderfer, D. M., Jones, L., Fan, J., Kirov, G., Perlis, R. H., et al. (2008) · Nature Genetics · doi:10.1038/ng.209 · Cited by 1,237
Excess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120
Goldstein, B. I., Carnethon, M. R., Matthews, K. A., McIntyre, R. S., Miller, G. E., Raghuveer, G., Stoney, C. M., Wasiak, H., & McCrindle, B. W. (2015) · Circulation · doi:10.1161/cir.0000000000000229 · Cited by 519
Heartache and heartbreak—the link between depression and cardiovascular disease
Nemeroff, C. B., & Goldschmidt-Clermont, P. J. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.91 · Cited by 424 · cited 2×
“These include overactivity of the hypothalamic–pituitary–adrenal axis,(1,33,34) neuroinflammation, oxidative stress,(1) and endothelial dysfunction.(1,35) Some of these systems, particularly the hypothalamic–pituitary–adrenal axis, may be influenced by antihypertensive medications.”
BackgroundCan bipolar disorder be viewed as a multi-system inflammatory disease?
Leboyer, M., Soreca, I., Scott, J., Frye, M., Henry, C., Tamouza, R., & Kupfer, D. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.049 · Cited by 417 · cited 2×
“There is also evidence that the brain renin–angiotensin system is involved in proinflammatory mechanisms that mainly affect regions responsible for emotion, which is implicated in mood states of BDs.10,11 However, epidemiological evidence for an association between any antihypertensive drug and neuropsychiatric conseq…”
BackgroundHypothalamic-pituitary-adrenal axis function in patients with bipolar disorder
Watson, S., Gallagher, P., Ritchie, J. C., Ferrier, I. N., & Young, A. H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.184.6.496 · Cited by 343
Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States
Goldstein, B. I., Fagiolini, A., Houck, P., & Kupfer, D. J. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00735.x · Cited by 259 · cited 1×
“3-fold increased risk of hypertension.(4) There is accruing data from animal model, epidemiological, and genomic studies that pathways and molecular targets of commonly used antihypertensive drugs may have a role in the pathogenesis or course of mood disorders.”
Background
Cited by
Brownstein, D. J., Salagre, E., Köhler, C., Stubbs, B., Vian, J., Pereira, C., Chavarria, V., Karmakar, C., Turner, A., Quevedo, J., et al. (2018) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867417721654 · Cited by 46
“These results were replicated in another study by Boal et al. (2016) which examined mood related hospital admissions of 144,660 patients treated with antihypertensive monotherapy for a five-year follow-up.”
ResultAngiotensin Receptor Blockers Are Not Just for Hypertension Anymore
Saavedra, J. M. (2021) · Physiology · doi:10.1152/physiol.00036.2020 · Cited by 37
Episodic Migraine and Psychiatric Comorbidity: A Narrative Review of the Literature
George, A., & Minen, M. T. (2023) · Current Pain and Headache Reports · doi:10.1007/s11916-023-01123-4 · Cited by 24
The risk of developing cardiovascular disease in bipolar disorder. Biological factors and therapy
Mosolov, S. N., & Fedorova, E. Y. (2022) · Terapevticheskii arkhiv · doi:10.26442/00403660.2022.04.201455 · Cited by 4
Metadata
- Authors
- Boal, A. H., Smith, D. J., McCallum, L., Muir, S., Touyz, R. M., Dominiczak, A. F., & Padmanabhan, S.
- Venue
- Hypertension
- Published
- 2016-11
- Volume
- 68
- Issue
- 5
- Pages
- 1132-1138
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2532329074
- Cited by
- 125
- References
- 16
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders. https://app.cochat.ai/papers/10.1161/hypertensionaha.116.08188
- The paper
- Boal, A. H., Smith, D. J., McCallum, L., Muir, S., Touyz, R. M., Dominiczak, A. F., & Padmanabhan, S. (2016). Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders. Hypertension. https://doi.org/10.1161/hypertensionaha.116.08188
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.